[1] |
Byard RW.Deep venous thrombosis,pulmonary embolism and long-distance flights[J].Forensic Sci Med Pathol,2019, 15(1):122-124.
|
[2] |
Traverso CI,Caprini JA,Arcelus JI.The normal thromboelastogram and its interpretation[J].Semin Thromb Hemost,1995,21(Suppl 4):7-13.
|
[3] |
Gosselin RC,Estacio EE,Song JY,et al.Verifying the performance characteristics of the TEG5000 thromboelastogram in the clinical laboratory[J].Int J Lab Hematol,2016,38(2):183-192.
|
[4] |
Hum J,Amador D,Shatzel JJ,et al.Thromboelastography Better Reflects Hemostatic Abnormalities in Cirrhotics Compared With the International Normalized Ratio[J].J Clin Gastroenterol,2020,54(8):741-746.
|
[5] |
Liu J,Wang N,Chen Y,et al.Thrombelastography coagulation index may be a predictor of venous thromboembolism in gynecological oncology patients[J].J Obstet Gynaecol Res,2017,43(1):202-210.
|
[6] |
Canakci ME,Acar N,Bilgin M,et al.Diagnostic value of point-of-care ultrasound in deep vein thrombosis in the emergency department[J].J Clin Ultrasound,2020,48(9):527-531.
|
[7] |
郭瑛,郝玉芝,张育荣.肿瘤患者血栓弹力图检测的状况分析及对血栓的诊断效能评价[J].国际检验医学杂志,2020,41(16):1999-2002.
|
[8] |
Abu Assab T,Raveh-Brawer D,Abramowitz J,et al.The Predictive Value of Thromboelastogram in the Evaluation of Patients with Suspected Acute Venous Thromboembolism[J].Acta Haematol,2020,143(3):272-278.
|
[9] |
Reitsma PH,Versteeg HH,Middeldorp S.Mechanistic view of risk factors for venous thromboembolism[J].Arterioscler Thromb Vasc Biol,2012,32(3):563-568.
|
[10] |
中华医学会外科学分会血管外科学组.深静脉血栓形成的诊断和治疗指南(第三版)[J].中国血管外科杂志(电子版),2017,9(4):250-257.
|
[11] |
Linkins LA,Takach Lapner S.Review of D-dimer testing:Good,Bad,and Ugly[J].Int J Lab Hematol,2017,39(Suppl 1):98-103.
|
[12] |
Zhu L,Li M,Liu Y.Intravenous Administration of Low-Molecular-Weight Heparin[J].Am J Ther,2019,26(3):e426-e428.
|
[13] |
Aleidan FAS,Aljarba GA,Aldakhil AA,et al.A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin[J].Int J Hematol,2020,112(1):1-7.
|
[14] |
Wang J,Zhu HL,Shi ZJ,et al.The Application of Thromboelastography in Understanding and Management of Ecchymosis After Total Knee Arthroplasty[J].J Arthroplasty,2018,33(12):3754-3758.
|
[15] |
Tong CK,Jin J,Du Q.Use of Thromboelastogram in Venovenous Extracorporeal Membrane Oxygenation for a Patient with Pulmonary Hemorrhage due to Microscopic Polyangiitis[J].Case Rep Crit Care,2019,2019:7241264.
|
[16] |
Zostautiene I,Zviniene K,Trepenaitis D,et al.Thromboelastographic changes during laparoscopic fundoplication[J].Wideochir Inne Tech Maloinwazyjne,2017,12(1):19-27.
|
[17] |
Eek AK,■ie E,Granas AG.Prescribing of NOACs has outnumbered warfarin:exploring how physicians choose anticoagulant treatments[J].Eur J Clin Pharmacol,2018,74(3):323-330.
|
[18] |
Riondino S,Ferroni P,Zanzotto FM,et al.Predicting VTE in Cancer Patients:Candidate Biomarkers and Risk Assessment Models[J].Cancers (Basel),2019,11(1):95.
|
[19] |
Gilbert BW,Adams TR,Reynolds TR,et al.Utilization of thromboelastography and a low molecular weight heparin anti-Xa assay for guidance in apixaban reversal:A case report[J].Am J Emerg Med,2019,37(10):1991.e1-1991.e3.
|
[20] |
Gantioqui J,Stevic I,Atkinson H,et al.Rivaroxaban and dabigatran did not affect clotting profiles in plasma reconstituted with varying levels of autologous platelets to the same degree as heparin when evaluated using thromboelastography[J].Blood Coagul Fibrinolysis,2018,29(6):521-527.
|
[21] |
Sakai T.Comparison between thromboelastography and thromboelastometry[J].Minerva Anestesiol,2019,85(12):1346-1356.
|
[22] |
Kumar SS,Sabu A.Fibrinolytic Enzymes for Thrombolytic Therapy[J].Adv Exp Med Biol,2019,1148:345-381.
|
[23] |
Stubblefield W,Kline J,Rondina M.Variable resistance to plasminogen activator initiated fibrinolysis for intermediate-risk pulmonary embolism[J].J Thromb Haemost,2015, 13:344.
|
[24] |
Long MT,Gallo PD,Hammel LL,et al.A Misguided Contraindication:International Normalized Ratio in Acute Liver Failure Precluding Thrombolysis for Massive Pulmonary Embolism:A Case Report[J].A A Pract,2019,12(4):99-102.
|
[25] |
Lin C,Fu Y,Huang S,et al.Rapid thrombelastography predicts perioperative massive blood transfusion in patients undergoing coronary artery bypass grafting:A retrospective study[J].Medicine (Baltimore),2020,99(37):e218-e233.
|
[26] |
Smolarz A,McCarthy P,Shmookler A,et al.Utilization of Thromboelastogram and Inflammatory Markers in the Management of Hypercoagulable State in Patients with COVID-19 Requiring ECMO Support[J].Case Rep Crit Care,2021, 2021:8824531.
|
[27] |
Boone BA,Murthy P,Miller-Ocuin J,et al.Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps[J].BMC Cancer,2018,18(1):678.
|
[28] |
Boon GJAM,Van Dam LF,Klok FAJ,et al.Management and treatment of deep vein thrombosis in special populations[J].Expert Rev Hematol,2018,11(9):685-695.
|
[29] |
孙镭.血栓弹力图(TEG)在关节置换围手术期血栓风险评估中的应用[D].济南:山东大学,2017,16(1):8-10.
|
[30] |
Chen Z,Ma Y,Li Q,et al.The application of thromboelastography in risk stratification for selective thromboembolism prophylaxis after total joint arthroplasty in Chinese:a randomized controlled trial[J].Ann Palliat Med,2020,9(5):2498-2507.
|
[31] |
Agha AM,Gill C,Balanescu DV,et al.Identifying Hemostatic Thresholds in Cancer Patients Undergoing Coronary Angiography Based on Platelet Count and Thromboelastography[J].Front Cardiovasc Med,2020,7:9.
|
[32] |
Makedonov I,Kahn SR,Galanaud JP.Prevention and Management of the Post-Thrombotic Syndrome[J].J Clin Med,2020,9(4):923.
|
[33] |
Harrison MF.The Misunderstood Coagulopathy of Liver Disease:A Review for the Acute Setting[J].West J Emerg Med,2018,19(5):863-871.
|
[34] |
Tanner B,Lu S,Zervoudakis G,et al.Coagulation profile following liver resection:Does liver cirrhosis affect thromboelastography?[J].Am J Surg,2018,215(3):406-409.
|
[35] |
Fidler H,Booth A,Hodgson HJ,et al.Portal vein thrombosis in myeloproliferative disease.Uses of thrombolytic and antiplatelet treatment[J].BMJ,1990,300(6724):590-592.
|
[36] |
Belcaro G,Dugall M,Hu S,et al.Prevention of recurrent venous thrombosis and post-thrombotic syndrome[J].Minerva Cardioangiol,2018,66(3):238-245.
|
[37] |
Weitz JI,Lensing AWA,Prins MH,et al.Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism[J].N Engl J Med,2017,376(13):1211-1222.
|
[38] |
Riondino S,Ferroni P,Zanzotto FM,et al.Predicting VTE in Cancer Patients:Candidate Biomarkers and Risk Assessment Models[J].Cancers (Basel),2019,11(1):95.
|
[39] |
Chopard R,Albertsen IE,Piazza G.Diagnosis and Treatment of Lower Extremity Venous Thromboembolism:A Review[J].JAMA,2020,324(17):1765-1776.
|
[40] |
Parakh RS,Sabath DE.Venous Thromboembolism:Role of the Clinical Laboratory in Diagnosis and Management[J].J Appl Lab Med,2019,3(5):870-882.
|
[41] |
王莹,郑贤芳,葛小花.血栓弹力图在妊娠期糖尿病孕妇凝血功能检测中的应用价值[J].中国当代医药,2020,27(30):4.
|